| Literature DB >> 25941576 |
Emilio Cano-Ramos1, Begoña Lavin2, Oscar M Pello1.
Abstract
Inhibition of MYC has been postulated as one of the most promising anti-tumoral therapies. However, if some anti-inflammatory cells express MYC, would an anti-tumoral treatment targeting MYC facilitate subsequent inflammation-related disorders?Entities:
Keywords: MYC; inflammation; macrophages; tumor
Year: 2014 PMID: 25941576 PMCID: PMC4292312 DOI: 10.4161/21624011.2014.956013
Source DB: PubMed Journal: Oncoimmunology ISSN: 2162-4011 Impact factor: 8.110